Replies to post #2842 on Galectin Therapeutics Inc. (GALT)

[Coolec78]

It also can be takeover if you guys remember KBIO.

[biotech2010]

I won't disagree with you on that, it's just that I think CNAT is a better option for the same $ at this point in time-they probably have a 75% chance of success with the prior data and partnership with NVTS, that's a $1.5B market cap using your estimate or $50 a share.